Fluidigm - About the company
Fluidigm is a public company based in San Francisco (United States), founded in 1999 by Gajus Worthington. It operates as a Developer of instruments for life sciences industries. Fluidigm has raised $40.5M in funding from investors like InterWest Partners, Lehman Brothers and EDBI. The company has 840 active competitors, including 71 funded and 139 that have exited. Its top competitors include companies like Siemens Healthineers, Agilent and Cepheid.
Company Details
Developer of instruments for life sciences industries. The company's product range includes the Access Array and Juno for NGS library preparation, Biomark HD, and EP1 for single-cell PCR applications and SNP genotyping assays, C1 for single-cell genomics, epigenomics, and transcriptomics, Callisto a platform for experiments involving the long-term culture of cells.
- Website
- fluidigm.com
- Social
- Email ID
- *****@fluidigm.com
- Phone Number
- +1 **********, +1 **********
- Registered Address
- South San Francisco, California
Key Metrics
Founded Year
1999
Location
San Francisco, United States
Stage
Public
Total Funding
$40.5M in 10 rounds
Latest Funding Round
Investors
Ranked
26th among 840 active competitors
Employee Count
511 as on May 31, 2026
Exit Details
Public
Legal entities associated with Fluidigm
Fluidigm is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Fluidigm Corporation CIN: 770513190 , United States, Active | Dec 26, 999 | - | 129 (As on Dec 31, 2024) | - |
Fluidigm's IPO details
Fluidigm got listed on Feb 10, 2011.
Click here to take a look at Fluidigm's IPO in detail
Sign up to download Fluidigm's company profile
Fluidigm's funding and investors
Fluidigm has raised a total funding of $40.5M over 10 rounds. Its first funding round was on Nov 21, 2004. Its latest funding round was a Post IPO round on Apr 01, 2022 for $*****. 2 investors participated in its latest round. Fluidigm has 18 institutional investors.
Here is the list of recent funding rounds of Fluidigm:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 01, 2022 | 2169543 | Post IPO | 2311001 | 8166098 | 6642996 | 3082618 |
Dec 14, 2020 | 6268144 | Grant (prize money) | 7722104 | 3637053 | 5611823 | |
Nov 20, 2019 | 1981904 | Post IPO | 1069453 | 3141959 | 1919547 | 6928137 |
Access funding benchmarks and valuations. Sign up today!View details of Fluidigm's funding rounds and investors
Fluidigm's founders and board of directors
Founder? Claim ProfileThe founders of Fluidigm is Gajus Worthington.
Here are the details of Fluidigm's key team members:
- Gajus Worthington: Former Founder of Fluidigm.
- Christopher Linthwaite: CEO of Fluidigm.
View details of Fluidigm's Founder profiles and Board Members
Fluidigm's employee count trend
Fluidigm has 511 employees as of May 26. Here is Fluidigm's employee count trend over the years:
Uncover Fluidigm's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Fluidigm's Competitors and alternates
Top competitors of Fluidigm include Siemens Healthineers, Agilent and Cepheid. Here is the list of Top 10 competitors of Fluidigm, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Siemens Healthineers 2017, Forchheim (Germany), Public | Provider of medical imaging laboratory diagnostics and clinical digital solutions | - | 75/100 | |
2nd | Agilent 1995, Santa Clara (United States), Public | Developer of diversified instruments for scientific and laboratory management | - | 73/100 | |
3rd | Cepheid 1996, Sunnyvale (United States), Acquired | Developer of molecular diagnostic testing solutions | $19.1M | 73/100 | |
4th | Illumina 1993, San Diego (United States), Public | Developer of technologies for analysis of genetic variation and function | $28M | 71/100 | |
5th | Quanterix 2007, Cambridge (United States), Public | Developer of assay kits for ultra-sensitive biomarker detection | $99.5M | 71/100 | |
6th | Bruker 1960, United States, Public | Manufacturer of high-performance scientific instruments for life sciences | - | 70/100 | |
7th | Developer of laboratory and biopharmaceutical equipment | - | 70/100 | ||
8th | Unchained Labs 2015, Pleasanton (United States), Acquired | Developer of multiplex protein stability platform for biologics | $111M | 68/100 | |
9th |  Esco Lifesciences 1978, Singapore (Singapore), Late Stage | Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools | $200M | 67/100 | |
10th | BioLife Solutions 1987, Bothell (United States), Acquired | Developer of cell and gene therapies with the integrity of a single cell | - | - | 67/100 |
26th | Fluidigm 1999, San Francisco (United States), Public | Developer of instruments for life sciences industries | $40.5M | 55/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Fluidigm's competitors? Click here to see the top ones
Fluidigm's Investments and acquisitions
Fluidigm has acquired 3 companies including InstruNor, DVS Sciences and ARCXIS. Fluidigm has not made any investments as of now.Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Feb 26, 2020 | Acquisition | 2011 | Fagerstrand (Norway) | |
Jan 29, 2014 | Acquisition | 2004 | San Francisco (United States) | |
2013 | Acquisition | 2004 | Pleasanton (United States) |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by Fluidigm
Reports related to Fluidigm
Here is the latest report on Fluidigm's sector:
News related to Fluidigm
Filter this list•
•
Standard BioTools to Restructure, Discontinue Certain Products as Q2 Revenues Drop 39 PercentGenomeWeb•Aug 09, 2022•Fluidigm
•
Evonetix Appoints Colin McCracken as Chief Executive OfficerUserwalls•Jun 13, 2022•Fluidigm, Evonetix
•
•
•
Fluidigm completes capital infusion; stock to start trading under new ticker on Apr 6Seeking Alpha•Apr 05, 2022•Fluidigm, Casdin Capital, Viking Global Investors
•
Valsoft Corporation welcomes Viking Global Investors as a minority investor - Valsoft Corporation - Acquisition of Vertical Software BusinessesValsoft•Mar 28, 2022•Valsoft, Viking Global Investors, Fluidigm, Caligan Partners and 6 others
•
Fluidigm Appeal in IonPath Patent Infringement Battle Voluntarily DismissedGenomeWeb•Mar 11, 2022•Fluidigm
•
Fluidigm Announces Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewswire•Feb 18, 2022•Fluidigm
•
Fluidigm Partners With Abu Dhabi Stem Cells Center on Therapy Development, ResearchGenomeWeb•Feb 17, 2022•Fluidigm
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Fluidigm
Explore our recently published companies
- Persistent Petrochem - Mumbai based, 2022 founded, Unfunded company
- SoftTalk - Noida based, 2026 founded, Unfunded company
- Gravity Base - Dubai based, 2014 founded, Unfunded company
- Terablaz Media - Ahmedabad based, 2023 founded, Unfunded company
- Way2Max - Jaipur based, 2021 founded, Unfunded company
- IATrain - Picos based, 2024 founded, Unfunded company
